Standard
Mount Sinai Researchers Reveal How APOE4 Drives Brain Damage and Open Doors to Reversible Treatments
In a significant breakthrough for the field of neurodegenerative research, scientists at Mount Sinai have unveiled new, granular details regarding how APOE4—the most potent genetic risk factor for Alzheimer’s disease—actively contributes to brain damage. Through two high-impact studies recently published in the journals Cell and Cell Stem Cell, the team has demonstrated that this gene…
